Michael Hoffman - Jan 3, 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Michael Hoffman
Stock symbol
ANVS
Transactions as of
Jan 3, 2022
Transactions value $
$10
Form type
4
Date filed
1/5/2022, 06:41 PM
Previous filing
Jul 9, 2021
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Options Exercise $132K +30K +2.16% $4.39 1.42M Jan 4, 2022 Direct
transaction ANVS Common Stock Tax liability -$132K -6.66K -0.47% $19.78 1.41M Jan 4, 2022 Direct F1
transaction ANVS Common Stock Options Exercise $1.79K +7.14K +0.51% $0.25* 1.42M Jan 4, 2022 Direct
transaction ANVS Common Stock Tax liability -$1.78K -90 -0.01% $19.78 1.42M Jan 4, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +9K $0.00 9K Jan 3, 2022 Common Stock 9K $19.78 Direct F3
transaction ANVS Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Jan 4, 2022 Common Stock 30K $4.39 Direct
transaction ANVS Stock Option (right to buy) Options Exercise $0 -7.14K -100% $0.00* 0 Jan 4, 2022 Common Stock 7.14K $0.25 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 6,658 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $4.39 per share to fund the cashless exercise of 30,000 options.
F2 Reflects 90 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $0.25 per share to fund the cashless exercise of 7,142 options.
F3 The stock option shall vest in eight consecutive quarterly installments of 1,125 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.